Author
DoP observes Swachhta Pakhwada
The department has involved various pharma and medical devices associations and their manufactures, traders, retailers and…
Biocon withdraws application for EU approval of two drugs
EU drugs regulator sought re-inspection of their production facility
Zydus Cadila receives US FDA approval for blood pressure drug
The drug will be manufactured at the groups formulations manufacturing facility at pharma SEZ in Ahmedabad
Zydus settles patent case over Aptalis’ drug Canasa
Canasa is indicated to treat mildly to moderately active ulcerative colitis
Natco gets US FDA nod to market renal disease drug
The product, as the first generic, will be launched shortly in the US market
Over 1,000 Jan Aushadhi Kendras to open in UP
The shops will be opened under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme
Repeated regulatory reprimands will erode investor confidence in DRL: Analysts
German regulator's observations on GMP violations include systemic data integrity issues
Divis Labs bags green nod
To modernise its bulk drug unit in Visakhapatnam which will entail a cost of Rs 100 crore